欧洲神经刺激设备市场预测至 2030 年 - 区域分析 - 按产品(脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等)、应用(疼痛管理、癫痫、尿失禁和大便失禁、帕金森病)疾病等)和最终用户(医院、专科诊所等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 91    |    Report Code: BMIRE00030035    |    Category: Life Sciences

Europe Neurostimulation Devices Market
2022年欧洲神经刺激设备市场价值为17.1784亿美元,预计到2030年将达到34.5924亿美元;据估计,从 2022 年到 2030 年,复合年增长率为 9.1%。 脊髓损伤病例的增加推动了欧洲神经刺激设备市场 由于容易患各种脊柱疾病的老年人口不断增加,神经刺激设备行业受到了关注。这些人群变得更容易患脊柱疾病,如退行性椎间盘疾病、骨关节炎、脊柱侧弯、脊柱肿瘤和椎管狭窄。随着人口老龄化,脊柱的自然磨损会导致多种脊柱疾病。因此,鉴于这一事实,人口老龄化给脊柱外科医生带来了独特的挑战,因为身体虚弱、合并症、营养状况下降以及术后并发症的可能性更高。根据世界卫生组织(WHO)2022年10月发布的数据,到2050年,约80%的老年人口将生活在低收入和中等收入国家,预计人口老龄化速度将大大加快。比过去更快。人口老龄化,加上生活方式相关因素,导致患有退行性椎间盘疾病和脊柱畸形等脊柱问题的人数大幅增加。因此,老年人和成年人脊髓损伤的高发生率刺激了对神经刺激设备的需求。欧洲神经刺激设备市场概述欧洲神经刺激设备市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。由于脑动脉瘤、中风等神经系统疾病的患病率不断上升,以及该地区市场参与者不断增加的产品创新,预计该地区市场在未来几年将显着增长。市场增长还归因于德国、法国和西班牙等国家医疗保健系统的发展以及主要区域公司推出的创新产品的增加。 2020年6月,美敦力宣布推出采用BrainsenseTM技术的PerceptTM PC神经刺激器。该技术同时记录并向大脑传送电刺激,以缓解帕金森病 (PD) 的症状。欧洲神经刺激设备市场收入和预测到 2030 年(百万美元) 欧洲神经刺激设备市场细分 欧洲神经刺激设备市场根据产品、应用、最终用户和国家/地区进行细分。根据产品,欧洲神经刺激设备市场分为脊髓刺激器、深部脑刺激器、骶神经刺激器、迷走神经刺激器等。脊髓刺激器细分市场在2022年占据最大的市场份额。从应用来看,欧洲神经刺激设备市场分为疼痛管理、癫痫、大小便失禁、帕金森病等。疼痛管理领域在 2022 年占据最大的市场份额。按最终用户划分,欧洲神经刺激设备市场分为医院、专科诊所等。到 2022 年,医院细分市场占据最大的市场份额。根据国家/地区,欧洲神经刺激设备市场分为英国、德国、法国、意大利、西班牙和欧洲其他地区。德国在 2022 年占据欧洲神经刺激设备市场份额。Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、ElectroCore Inc 和 Mainstay Medical 是欧洲神经刺激设备市场上的一些领先公司。

Europe Neurostimulation Devices Strategic Insights

Strategic insights for Europe Neurostimulation Devices involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-neurostimulation-devices-market-strategic-framework.webp
Get more information on this report

Europe Neurostimulation Devices Report Scope

Report Attribute Details
Market size in 2022 US$ 1,717.84 Million
Market Size by 2030 US$ 3,459.24 Million
Global CAGR (2022 - 2030) 9.1%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 脊髓刺激器
  • 深部脑刺激器
  • 骶神经刺激器
  • 迷走神经刺激器
By 应用
  • 疼痛管理
  • 癫痫
  • 尿失禁和大便失禁
  • 帕金森病
By 最终用户
  • 医院
  • 专科诊所
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc
  • ElectroCore Inc
  • Mainstay Medical
  • Get more information on this report

    Europe Neurostimulation Devices Regional Insights

    The regional scope of Europe Neurostimulation Devices refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-neurostimulation-devices-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Neurostimulation Devices Market

    1. Medtronic Plc

    2. Boston Scientific Corp

    3. Abbott Laboratories

    4. Nevro Corp

    5. LivaNova Plc

    6. Synapse Biomedical Inc

    7. ElectroCore Inc

    8. Mainstay Medical

    Frequently Asked Questions
    How big is the Europe Neurostimulation Devices Market?

    The Europe Neurostimulation Devices Market is valued at US$ 1,717.84 Million in 2022, it is projected to reach US$ 3,459.24 Million by 2030.

    What is the CAGR for Europe Neurostimulation Devices Market by (2022 - 2030)?

    As per our report Europe Neurostimulation Devices Market, the market size is valued at US$ 1,717.84 Million in 2022, projecting it to reach US$ 3,459.24 Million by 2030. This translates to a CAGR of approximately 9.1% during the forecast period.

    What segments are covered in this report?

    The Europe Neurostimulation Devices Market report typically cover these key segments-

  • 产品 (脊髓刺激器, 深部脑刺激器, 骶神经刺激器, 迷走神经刺激器)
  • 应用 (疼痛管理, 癫痫, 尿失禁和大便失禁, 帕金森病)
  • 最终用户 (医院, 专科诊所)
  • What is the historic period, base year, and forecast period taken for Europe Neurostimulation Devices Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neurostimulation Devices Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Neurostimulation Devices Market?

    The Europe Neurostimulation Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc
  • ElectroCore Inc
  • Mainstay Medical
  • Who should buy this report?

    The Europe Neurostimulation Devices Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Neurostimulation Devices Market value chain can benefit from the information contained in a comprehensive market report.